Features of skin itching in HIV-infected patients with atopic dermatitis

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The review article analyzes current data on the role of various parts of the central and peripheral nervous systems, as well as individual sensory nerve fibers and skin receptors in the development of skin itching. Itching receptors are listed with their characteristics and fundamental differences for sensory nerve fibers. Information on significant endogenous factors of itching is systematized with an analysis of the most significant causes. The article presents an analysis of clinical and research data related to the involvement of individual blood cells as triggers in the development of skin itching. Facts indicating creative connections between leukocytes (neutrophils, eosinophils) and platelets in cases of itching formation and maintenance have been revealed. The significance of the mean volume and shape of platelets in the development of persistent skin itching in patients with atopic dermatitis (AD) is shown. Important links in the development of skin itching in HIV-infected patients due to HIV-mediated effects of platelet activation are presented. An opinion on the role of individual cytokines in the development of itching in patients with AD and the function of these cytokines in the pathogenesis of HIV infection is expressed. The importance of antiretroviral therapy (ART) in HIV-infected patients in order to reduce the production of cytokines associated with skin itching is demonstrated. In addition, the data of modern studies on the role of short-chain fatty acids (SCFAs) in the development and maintenance of skin itching in patients with AD are collected. The importance of SCFAs in embryogenesis and the functioning of the central and peripheral nervous systems is indicated. The role of SCFAs in the modulation of inflammatory reactions of immunocompetent cells is considered. Information on the role of endogenous predictors of itching in the pathogenesis of HIV infection in patients with AD is concentrated.

全文:

受限制的访问

作者简介

E. Evdokimov

Polyclinic No. 1 of the Administrative Directorate of the President of the Russian Federation; Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

编辑信件的主要联系方式.
Email: evdokimovevg@yandex.ru
ORCID iD: 0000-0003-2694-8900

Dr. Sci. (Med.), Leading Researcher, Clinical Department

俄罗斯联邦, Moscow; Moscow

E. Svechnikova

Polyclinic No. 1 of the Administrative Directorate of the President of the Russian Federation; Russian Biotechnology University (ROSBIOTECH)

Email: evdokimovevg@yandex.ru
ORCID iD: 0000-0002-5885-4872
俄罗斯联邦, Moscow; Moscow

Zh. Ponezheva

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: evdokimovevg@yandex.ru
ORCID iD: 0000-0002-6539-4878
俄罗斯联邦, Moscow

E. Gorelova

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: evdokimovevg@yandex.ru
ORCID iD: 0000-0002-3450-4851
俄罗斯联邦, Moscow

参考

  1. Savin J.A. How should we define itching? J Am Acad Dermatol. 1998 Aug;39(2 Pt 1):268-9. doi: 10.1016/s0190-9622(98)70087-8.
  2. Harrison I.P., Spada F. Breaking the Itch-Scratch Cycle: Topical Options for the Management of Chronic Cutaneous Itch in Atopic Dermatitis. Medicines (Basel). 2019 Jul 18;6(3):76. doi: 10.3390/medicines6030076.
  3. Атопический дерматит: клинические рекомендации. Общероссийская общественная организация «Российское общество дерматовенерологов и косметологов», Общероссийская общественная организация «Российская ассоциация аллергологов и клинических иммунологов», Общероссийская общественная организация «Союз педиатров России», при участии Союза «Национальный альянс дерматовенерологов и косметологов», 2022. [Atopic dermatitis: clinical recommendations. All-Russian public organization «Russian Society of Dermatovenerologists and Cosmetologists», All-Russian public organization «Russian Association of Allergologists and Clinical Immunologists», All-Russian public organization «Union of Pediatricians of Russia», with the participation of the Union «National Alliance of Dermatovenerologists and Cosmetologists», 2022. (In Russ.)].
  4. Xing Y., Chen J., Hilley H., et al. Molecular Signature of Pruriceptive MrgprA3+ Neurons. J Invest Dermatol. 2020 Oct;140(10):2041–2050. doi: 10.1016/j.jid.2020.03.935.
  5. Sharma N., Flaherty K., Lezgiyeva K., et al. The emergence of transcriptional identity in somatosensory neurons. Nature. 2020 Jan;577(7790):392–398. doi: 10.1038/s41586-019-1900-1.
  6. Han L., Ma C., Liu Q., et al. A subpopulation of nociceptors specifically linked to itch. Nat Neurosci. 2013 Feb;16(2):174-82. doi: 10.1038/nn.3289.
  7. Solinski H.J., Kriegbaum M.C., Tseng P.Y., et al. Nppb Neurons Are Sensors of Mast Cell-Induced Itch. Cell Rep. 2019 Mar 26;26(13):3561–3573.e4. doi: 10.1016/j.celrep.2019.02.089.
  8. Адаскевич В.П. Кожный зуд. Дерматологический и междисциплинарный феномен. М.: Изд. Панфилова, 2014 265 с.: илл. [Adaskevich V.P. Skin itching. Dermatological and interdisciplinary phenomenon. M.: Panfilov Publishing House; 2014. 265 p.: ill. (In Russ.)].
  9. Abdel-Magid A.F. Dual Inhibition of IL-2-Inducible T-Cell Kinase (ITK) and Tropomyosin Receptor Kinase A (TRKA) as Potential Treatment for Atopic Dermatitis and Other Inflammatory and Autoimmune Diseases. ACS Med Chem Lett. 2021 Nov 19;12(12):1889–1891. doi: 10.1021/acsmedchemlett.1c00619.
  10. Fiebig A., Leibl V., Oostendorf D., et al. Peripheral signaling pathways contributing to non-histaminergic itch in humans. J Transl Med. 2023;21:908. doi: 10.1186/s12967-023-04698-z.
  11. Dong X., Dong X. Peripheral and Central Mechanisms of Itch. Neuron. 2018 May 2;98(3):482–494. doi: 10.1016/j.neuron.2018.03.023.
  12. Liu T., Ji R.R. New insights into the mechanisms of itch: are pain and itch controlled by distinct mechanisms? Pflugers Arch. 2013 Dec;465(12):1671-85. doi: 10.1007/s00424-013-1284-2.
  13. Lay M., Dong X. Neural Mechanisms of Itch. Annu Rev Neurosci. 2020 Jul 8;43:187-205. doi: 10.1146/annurev-neuro-083019-024537.
  14. Cevikbas F., Lerner E.A. Physiology and Pathophysiology of Itch. Physiol Rev. 2020 Jul 1;100(3):945-982. doi: 10.1152/physrev.00017.2019.
  15. McGirt L.Y., Beck L.A. Innate immune defects in atopic dermatitis. J Allergy Clin Immunol. 2006;118(1):202–208. doi: 10.1016/j.jaci.2006.04.033.
  16. Fania L., Moretta G., Antonelli F., et al. Multiple Roles for Cytokines in Atopic Dermatitis: From Pathogenic Mediators to Endotype-Specific Biomarkers to Therapeutic Targets. International Journal of Molecular Sciences. 2022;23(5):2684. doi: 10.3390/ijms23052684.
  17. Radonjic-Hoesli S., Bruggen M.C., Feldmeyer L., et al. Eosinophils in skin diseases. Semin Immunopathol. 2021 Jun;43(3):393–409. doi: 10.1007/s00281-021-00868-7.
  18. Walsh C.M., Hill R.Z., Schwendinger-Schreck J., et al. Neutrophils promote CXCR3-dependent itch in the development of atopic dermatitis. Elife. 2019 Oct 21;8:e48448. doi: 10.7554/eLife.48448.
  19. Akbarzadeh R., Czyz C., Thomsen S.Y., et al. Monocyte populations are involved in the pathogenesis of experimental epidermolysis bullosa acquisita. Front Immunol. 2023 Dec 5;14:1241461. doi: 10.3389/fimmu.2023.1241461.
  20. Gandhi N.A., Pirozzi G., Graham N.M. Commonality of the IL-4/IL-13 pathway in atopic diseases. Expert Rev Clin Immunol. 2017;13(5):425–437. doi: 10.1080/1744666X.2017.1298443.
  21. Luo J., Feng J., Yu G., et al. Transient receptor potential vanilloid 4-expressing macrophages and keratinocytes contribute differentially to allergic and nonallergic chronic itch. J Allergy Clin Immunol. 2018 Feb;141(2):608-619.e7. doi: 10.1016/j.jaci.2017.05.051.
  22. Jing P.B., Cao D.L., Li S.S., et al. Chemokine Receptor CXCR3 in the Spinal Cord Contributes to Chronic Itch in Mice. Neurosci Bull. 2018 Feb;34(1):54–63. doi: 10.1007/s12264-017-0128-z.
  23. Sturm E.M., Knuplez E., Marsche G. Role of Short Chain Fatty Acids and Apolipoproteins in the Regulation of Eosinophilia-Associated Diseases. Int J Mol Sci. 2021 Apr 22;22(9):4377. doi: 10.3390/ijms22094377.
  24. Ali R.A., Wuescher L.M., Worth R.G. Platelets: essential components of the immune system. Curr Trends Immunol. 2015;16:65-78.
  25. Marx C., Novotny J., Salbeck D., et al. Eosinophil-platelet interactions promote atherosclerosis and stabilize thrombosis with eosinophil extracellular traps. Blood. 2019 Nov 21;134(21):1859-1872. doi: 10.1182/blood.2019000518.
  26. Shah S.A., Page C.P., Pitchford S.C. Platelet-Eosinophil Interactions As a Potential Therapeutic Target in Allergic Inflammation and Asthma. Front Med (Lausanne). 2017 Aug 8;4:129. doi: 10.3389/fmed.2017.00129.
  27. Akcal O., Taskırdı I. Do Platelet Count and mean Platelet Volume have a Predictive Role as a Marker in Children with Atopic Dermatitis? Indian J Dermatol. 2022 Nov-Dec;67(6):688–692. doi: 10.4103/ijd.ijd_689_22.
  28. Luo L., Zhang J., Lee J., Tao A. Platelets, Not an Insignificant Player in Development of Allergic Asthma. Cells. 2021 Aug 10;10(8):2038. doi: 10.3390/cells10082038.
  29. Sun S., Dong X. Trp channels and itch. Semin Immunopathol. 2016 May;38(3):293-307. doi: 10.1007/s00281-015-0530-4.
  30. Albrecht M., Dittrich A.M. Expression and function of histamine and its receptors in atopic dermatitis. Mol Cell Pediatr. 2015 Dec;2(1):16. doi: 10.1186/s40348-015-0027-1.
  31. Fukasawa T., Yoshizaki-Ogawa A., Enomoto A., et al. Pharmacotherapy of Itch-Antihistamines and Histamine Receptors as G Protein-Coupled Receptors. Int J Mol Sci. 2022 Jun 13;23(12):6579. doi: 10.3390/ijms23126579.
  32. Coppola S., Avagliano C., Sacchi A., et al. Potential Clinical Applications of the Postbiotic Butyrate in Human Skin Diseases. Molecules. 2022;27(6):1849. doi: 10.3390/molecules27061849.
  33. Thiruvengadam M., Subramanian U., Venkidasa-my B., et al. Emerging role of nutritional short-chain fatty acids (SCFAs) against cancer via modulation of hematopoiesis. Crit Rev Food Sci Nutr. 2023;63(6):827–844. doi: 10.1080/10408398.2021.1954874.
  34. Krishnan S., Ding Y., Saedi N., et al. Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages. Cell Rep. 2018 Apr 24;23(4):1099–1111. doi: 10.1016/j.celrep.2018.03.109. Erratum in: Cell Rep. 2019 Sep 17;28(12):3285.
  35. Theiler A., Bаrnthaler T., Platzer W., et al. Butyrate ameliorates allergic airway inflammation by limiting eosinophil trafficking and survival. J Allergy Clin Immunol. 2019 Sep;144(3):764–776. doi: 10.1016/j.jaci.2019.05.002.
  36. Cerdo T., Dieguez E., Campoy C. Early nutrition and gut microbiome: interrelationship between bacterial metabolism, immune system, brain structure, and neurodevelopment. Am J Physiol Endocrinol Metab. 2019 Oct 1;317(4):E617–E630. doi: 10.1152/ajpendo.00188.2019.
  37. Silva Y.P., Bernardi A., Frozza R.L. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Front Endocrinol (Lausanne). 2020 Jan 31;11:25. doi: 10.3389/fendo.2020.00025.
  38. Deng F.L., Pan J.X., Zheng P., et al. Metabonomics reveals peripheral and central short-chain fatty acid and amino acid dysfunction in a naturally occurring depressive model of macaques. Neuropsychiatr Dis Treat. 2019 May 1;15:1077–1088. doi: 10.2147/NDT.S186071.
  39. Zhang L., Wang Y., Xiayu X., et al. Altered Gut Microbiota in a Mouse Model of Alzheimer’s Disease. J Alzheimers Dis. 2017;60(4):1241–1257. doi: 10.3233/JAD-170020.
  40. Janocha-Litwin J., Simon K. Neurological Disorders of Patients Living with HIV Hospitalized in Infectious Departments of the Specialist Hospital in Lower Silesia in Poland. Healthcare. 2022;10:1481. doi: 10.3390/healthcare10081481.
  41. Avdoshina V., Yumoto F., Mocchetti I., et al. Race-Dependent Association of Single-Nucleotide Polymorphisms in TrkB Receptor in People Living with HIV and Depression. Neurotox Res. 2021 Dec;39(6):1721–1731. doi: 10.1007/s12640-021-00406-1.
  42. Wahl A., Al-Harthi L. HIV infection of non-classical cells in the brain. Retrovirology. 2023;20(1):1. doi: 10.1186/s12977-023-00616-9.
  43. Chimbetete T., Buck C., Choshi P., et al. HIV-Associated Immune Dysregulation in the Skin: A Crucible for Exaggerated Inflammation and Hypersensitivity. J Invest Dermatol. 2023 Mar;143(3):362–373. doi: 10.1016/j.jid.2022.07.035.
  44. Madzime M., Rossouw T.M., Theron A.J., et al. Interactions of HIV and Antiretroviral Therapy With Neutrophils and Platelets. Front Immunol. 2021 Mar 12:12:634386. doi: 10.3389/fimmu.2021.634386.
  45. Kumar P.S., Radhakrishnan A., Mukherjee T., et al. Understanding the role of Ca2+ via transient receptor potential (TRP) channel in viral infection: Implications in developing future antiviral strategies. Virus Res. 2023 Jan 2;323:198992. doi: 10.1016/j.virusres.2022.198992.
  46. Omar A., Marques N., Crawford N. Cancer and HIV: The Molecular Mechanisms of the Deadly Duo. Cancers. 2024;16(3):546. doi: 10.3390/cancers16030546.
  47. Gour N., Dong X. The MRGPR family of receptors in immunity. Immunity. 2024 Jan 9;57(1):28–39. doi: 10.1016/j.immuni.2023.12.012.
  48. Gama W.M., Oliveira L.B., Chaves Y.O., et al. Increased levels of reactive oxygen species in platelets and platelet-derived microparticles and the risk of respiratory failure in HIV/AIDS patients. Mem Inst Oswaldo Cruz. 2020 Sep 14;115:e200082. doi: 10.1590/0074-02760200082.
  49. Awamura T., Nakasone E.S., Gangcuangco L.M., et al. Platelet and HIV Interactions and Their Contribution to Non-AIDS Comorbidities. Biomolecules. 2023 Nov 2;13(11):1608. doi: 10.3390/biom13111608.
  50. Hensley-McBain T., Klatt N.R. The Dual Role of Neutrophils in HIV Infection. Curr HIV/AIDS Rep. 2018 Feb;15(1):1–10. doi: 10.1007/s11904-018-0370-7.
  51. Chou A, Serpa JA. Eosinophilia in patients infected with human immunodeficiency virus. Curr HIV/AIDS Rep. 2015 Sep;12(3):313-6. doi: 10.1007/s11904-015-0272-x.
  52. Симонов Р.О., Валишин Д.А. «Клинико-лабораторные особенности гельминтозов у ВИЧ-инфицированных пациентов» Инфекционные болезни: Новости. Мнения. Обучение. 2020; 9(2[33]):64–69. [Simonov R.O., Valishin D.A. «Clinical and laboratory features of helminthiasis in HIV-infected patients» Infectious diseases: News. Opinions. Education. 2020;9(2[33]):64–69. (In Russ.)]. doi: 10.33029/2305-3496-2020-9-2-64-69.
  53. Shete A., Kurle S., Dhayarkar S., et al. High IL-5 levels possibly contributing to HIV viremia in virologic non-responders at one year after initiation of anti-retroviral therapy. Microb Pathog. 2020 Jun;143:104117. doi: 10.1016/j.micpath.2020.104117.
  54. Papasavvas E., Sun J., Luo Q., et al. IL-13 acutely augments HIV-specific and recall responses from HIV-1-infected subjects in vitro by modulating monocytes. J Immunol. 2005 Oct 15;175(8):5532–40. doi: 10.4049/jimmunol.175.8.5532.
  55. Ramaswami R., Lurain K., Marshall V.A., et al. Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other Kaposi sarcoma herpesvirus-associated disorders. AIDS. 2021 Jan 1;35(1):53–62. doi: 10.1097/QAD.0000000000002692.
  56. Yan C., Xu H., Rong C., et al. IL-31 expression in HIV-infected patients with different routes of disease transmission. Medicine (Baltimore). 2022 Jun 24;101(25):e29509. doi: 10.1097/MD.0000000000029509.
  57. Essomba R.G., Mbe R.M., Ngogang M.P., et al. Plasma IL-33 levels and immune activation in HIV-TB coinfection: a cross-sectional study in Yaounde, Cameroon. Pan Afr Med J. 2023 Sep 11;46:13. doi: 10.11604/pamj.2023.46.13.41152.
  58. Song S.T., Wu M.L., Zhang H.J., et al. Mast Cell Activation Triggered by Retrovirus Promotes Acute Viral Infection. Front Microbiol. 2022 Feb 7;13:798660. doi: 10.3389/fmicb.2022.798660.
  59. Weisshaar E. Antihistaminika bei Pruritus : Das Ende einer Ara? [Antihistamines for treating pruritus : The end of an era?]. Hautarzt. 2020 Jul;71(7):525–527. German. doi: 10.1007/s00105-020-04617-z.
  60. Snyder L.M., Kuzirian M.S., Ross S.E. An Unexpected Role for TRPV4 in Serotonin-Mediated Itch. J Invest Dermatol. 2016 Jan;136(1):7–9. doi: 10.1016/j.jid.2015.11.010.
  61. Tahir M.Y., Mumang A.A., Kadar K.S., et al. Serotonin Levels in Newly-Infected HIV-Positive: A Preliminary Study. Med Arch. 2024;78(1):55–59. doi: 10.5455/medarh.2024.78.55-59.
  62. Oliveira M.S., da Silva Torquato B.G., Tsuji S.Y., et al. Morphological and Histopathological Study of Autopsied Patients with Atherosclerosis and HIV. Curr HIV Res. 2021 Feb 26;19(2):121–127. doi: 10.2174/1570162X18999201029123356.
  63. Beyens M., Toscano A., Ebo D., et al. Diagnostic Significance of Tryptase for Suspected Mast Cell Disorders. Diagnostics. 2023;13(24):3662. doi: 10.3390/diagnostics13243662.
  64. Pejler G. Novel Insight into the in vivo Function of Mast Cell Chymase: Lessons from Knockouts and Inhibitors. J Innate Immun. 2020;12(5):357–372. doi: 10.1159/000506985.
  65. Chatterjee T., Arora I., Underwood L., et al. High Heme and Low Heme Oxygenase-1 Are Associated with Mast Cell Activation/Degranulation in HIV-Induced Chronic Widespread Pain. Antioxidants. 2023;12(6):1213. doi: 10.3390/antiox12061213.
  66. Schwartz L., Spitsin S.V., Meshki J., et al. Substance P enhances HIV-1 infection in human fetal brain cell cultures expressing full-length neurokinin-1 receptor. J Neurovirol. 2013 Jun;19(3):219–27. doi: 10.1007/s13365-013-0166-x.
  67. Paramita D.A., Nasution K., Lubis N.Z. Relationship of Substance P with the Degree of Atopic Dermatitis Severity. Clin Cosmet Investig Dermatol. 2021 May 25;14:551–555. doi: 10.2147/CCID.S306557.
  68. McLaurin K.A., Harris M., Madormo V., et al. HIV-Associated Apathy/Depression and Neurocognitive Impairments Reflect Persistent Dopamine Deficits. Cells. 2021 Aug 21;10(8):2158. doi: 10.3390/cells10082158.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2024